Adrian J. Dunn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Adrian J. Dunn has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Artur H. Swiergiel
Department of Pharmacology, Toxicology and Neuroscience, Louisiana State University Health Sciences Center, Shreveport, P.O. Box 33932, Louisiana, USA
4 shared publications- Marek Wieczorek
Department of Neurobiology, Faculty of Biology and Environmental Protection, University of Łodz, Łodz, Poland
2 shared publications A H Swiergiel
Department of Pharmacology and Therapeutics, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130‐3932, USA
1 shared publicationHao Zhang
Department of Oral Biology, Ohio State University, Columbus, Ohio, USA
1 shared publicationNatalie R. Lenard
Pennington Biomedical Research Center, Baton Rouge, LA, USA
1 shared publicationNing Quan
Department of Oral Biology, Ohio State University, Columbus, Ohio, USA
1 shared publication
Latest Publications
- 1 April 2007
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 86 (4) , 651-659
Effects of interleukin-1β and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests
- 1 April 2007
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 86 (4) , 651-659
Effects of interleukin-1β and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests
- Open Access
- 1 November 2006
- Published by S. Karger AG in Neuroimmunomodulation
- Vol. 13 (2) , 96-104
Reduced Ingestion of Sweetened Milk Induced by Interleukin-1 and Lipopolysaccharide Is Associated with Induction of Cyclooxygenase-2 in Brain Endothelia
Previous studies have shown that interleukin-1 (IL-1) and lipopolysaccharide (LPS) administration to animals induces behavioral changes, including a reduction in feeding. These effects of IL-1 and LPS have been shown to be sensitive to inhibitors of cyclooxygenase (COX). Objectives: To determine the relationships between induction of COX-2 in the brain with IL-1β- and LPS-induced changes in body temperature, plasma corticosterone and feeding. Methods: Mice were injected with intraperitoneal doses of IL-1β and LPS that decreased feeding. The induction of COX-2 was studied immunocytochemically in the brain, in parallel with core body temperature, the drinking of sweetened milk, and plasma concentrations of corticosterone. Results: COX-2 immunoreactivity (ir) was sparse in the brains of the untreated mice, but IL-1β and LPS both increased its expression. This COX-2 induction appeared to be confined to blood vessels, and was not markedly region specific. Induction was evident 30 min after IL-1 or LPS, and was greater at 90 than at 30 min. COX-2-ir in the parenchyma did not change significantly. Thus induction of COX-2 occurred in brain endothelia in parallel with the reduction in feeding. This is consistent with the previously determined sensitivity of IL-1-induced changes in feeding to selective COX-2 inhibitors, and the responses to IL-1 in COX-2-deficient mice. The time courses of the IL-1- and LPS-induced increases in plasma corticosterone paralleled those in the reduction in milk drinking, however, the changes in body temperature appeared later. Conclusions: Endothelial COX-2 may be involved in IL-1- and LPS-induced decreases in milk drinking, and possibly in the HPA axis activation. The decreased milk drinking may occur when IL-1 and LPS bind to receptors on brain endothelial cells subsequently inducing COX-2 and the production of prostanoids which elicit the reductions in milk drinking. Thus the behavioral effects of peripherally administered IL-1 and LPS appear to be mediated by multiple mechanisms, including endothelial COX-2, and vagal afferents.
- 1 November 2006
- Published by S. Karger AG in Neuroimmunomodulation
- Vol. 13 (2) , 96-104
Open AccessReduced Ingestion of Sweetened Milk Induced by Interleukin-1 and Lipopolysaccharide Is Associated with Induction of Cyclooxygenase-2 in Brain Endothelia
Previous studies have shown that interleukin-1 (IL-1) and lipopolysaccharide (LPS) administration to animals induces behavioral changes, including a reduction in feeding. These effects of IL-1 and LPS have been shown to be sensitive to inhibitors of cyclooxygenase (COX). Objectives: To determine the relationships between induction of COX-2 in the brain with IL-1β- and LPS-induced changes in body temperature, plasma corticosterone and feeding. Methods: Mice were injected with intraperitoneal doses of IL-1β and LPS that decreased feeding. The induction of COX-2 was studied immunocytochemically in the brain, in parallel with core body temperature, the drinking of sweetened milk, and plasma concentrations of corticosterone. Results: COX-2 immunoreactivity (ir) was sparse in the brains of the untreated mice, but IL-1β and LPS both increased its expression. This COX-2 induction appeared to be confined to blood vessels, and was not markedly region specific. Induction was evident 30 min after IL-1 or LPS, and was greater at 90 than at 30 min. COX-2-ir in the parenchyma did not change significantly. Thus induction of COX-2 occurred in brain endothelia in parallel with the reduction in feeding. This is consistent with the previously determined sensitivity of IL-1-induced changes in feeding to selective COX-2 inhibitors, and the responses to IL-1 in COX-2-deficient mice. The time courses of the IL-1- and LPS-induced increases in plasma corticosterone paralleled those in the reduction in milk drinking, however, the changes in body temperature appeared later. Conclusions: Endothelial COX-2 may be involved in IL-1- and LPS-induced decreases in milk drinking, and possibly in the HPA axis activation. The decreased milk drinking may occur when IL-1 and LPS bind to receptors on brain endothelial cells subsequently inducing COX-2 and the production of prostanoids which elicit the reductions in milk drinking. Thus the behavioral effects of peripherally administered IL-1 and LPS appear to be mediated by multiple mechanisms, including endothelial COX-2, and vagal afferents.
- 1 September 2006
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 20 (5) , 477-487
Relationships among the behavioral, noradrenergic, and pituitary–adrenal responses to interleukin-1 and the effects of indomethacin
- 1 September 2006
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 20 (5) , 477-487
Relationships among the behavioral, noradrenergic, and pituitary–adrenal responses to interleukin-1 and the effects of indomethacin
- 1 August 2006
- Published by Elsevier in Clinical Neuroscience Research
- Vol. 6 (1-2) , 52-68
Effects of cytokines and infections on brain neurochemistry
- 1 August 2006
- Published by Elsevier in Clinical Neuroscience Research
- Vol. 6 (1-2) , 52-68
Effects of cytokines and infections on brain neurochemistry
- 1 July 2006
- Published by Elsevier in Brain Research
- Vol. 1101 (1) , 73-84
Effect of subdiaphragmatic vagotomy on the noradrenergic and HPA axis activation induced by intraperitoneal interleukin-1 administration in rats
- 1 July 2006
- Published by Elsevier in Brain Research
- Vol. 1101 (1) , 73-84
Effect of subdiaphragmatic vagotomy on the noradrenergic and HPA axis activation induced by intraperitoneal interleukin-1 administration in rats
- 1 December 2005
- Published by Springer Nature in Neurochemical Research
- Vol. 30 (12) , 1543-1548
Mechanisms and Significance of the Increased Brain Uptake of Tryptophan
Changes in brain tryptophan concentrations may affect the synthesis of brain serotonin (5-hydroxytryptamine, 5-HT). Concentrations of tryptophan are regulated more than those of any other amino acid. Such stimuli as acute stress, carbohydrate ingestion, and treatment with various drugs increase the brain content of tryptophan. Treatment of rats and mice with interleukin-1 (IL-1), interleukin-6 (IL-6), lipopolysaccharide (LPS), and β-adrenoceptor agonists, as well as a variety of stressors, such as footshock and restraint, all increase brain concentrations of tryptophan. The peak effect following both acute stress and β-adrenoceptor agonist administration occurs within 30–60 min, whereas the peak effect following LPS and the cytokines occurs much later at around 4–8 h. Experiments using the ganglionic blocker chlorisondamine, and β-adrenoceptor antagonists suggest that the sympathetic nervous system plays an important role in the modulation of brain tryptophan concentrations. The mechanisms involved in the increases observed in brain tryptophan are discussed, as well as their possible biological significance.
- 1 December 2005
- Published by Springer Nature in Neurochemical Research
- Vol. 30 (12) , 1543-1548
Mechanisms and Significance of the Increased Brain Uptake of Tryptophan
Changes in brain tryptophan concentrations may affect the synthesis of brain serotonin (5-hydroxytryptamine, 5-HT). Concentrations of tryptophan are regulated more than those of any other amino acid. Such stimuli as acute stress, carbohydrate ingestion, and treatment with various drugs increase the brain content of tryptophan. Treatment of rats and mice with interleukin-1 (IL-1), interleukin-6 (IL-6), lipopolysaccharide (LPS), and β-adrenoceptor agonists, as well as a variety of stressors, such as footshock and restraint, all increase brain concentrations of tryptophan. The peak effect following both acute stress and β-adrenoceptor agonist administration occurs within 30–60 min, whereas the peak effect following LPS and the cytokines occurs much later at around 4–8 h. Experiments using the ganglionic blocker chlorisondamine, and β-adrenoceptor antagonists suggest that the sympathetic nervous system plays an important role in the modulation of brain tryptophan concentrations. The mechanisms involved in the increases observed in brain tryptophan are discussed, as well as their possible biological significance.
- 1 January 2005
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 29 (4-5) , 891-909
Cytokines as mediators of depression: What can we learn from animal studies?
- 1 January 2005
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 29 (4-5) , 891-909
Cytokines as mediators of depression: What can we learn from animal studies?
- 1 June 2004
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1018 (1) , 25-34
Brain Circuits Involved in Corticotropin‐Releasing Factor‐Norepinephrine Interactions during Stress
Abstract: Corticotropin‐releasing factor (CRF)‐ and norepinephrine (NE)‐containing neurons in the brain are activated during stress, and both have been implicated in the behavioral responses. NE neurons in the brain stem can stimulate CRF neurons in the hypothalamic paraventricular nucleus (PVN) to activate the hypothalamic‐pituitary‐adrenocortical axis and may affect other CRF neurons. CRF‐containing neurons in the PVN, the amygdala, and other brain areas project to the area of the locus coeruleus (LC), and CRF injected into the LC alters the electrophysiologic activity of LC‐NE neurons. Neurochemical studies have indicated that CRF applied intracerebroventricularly or locally activates the LC‐NE system, and microdialysis and chronoamperometric measurements indicate increased NE release in LC‐NE terminal fields. However, chronoamperometric studies indicated a significant delay in the increase in NE release, suggesting that the CRF input to LC‐NE neurons is indirect. The reciprocal interactions between cerebral NE and CRF systems have been proposed to create a “feed‐forward” loop. It has been postulated that a sensitization of such a feed‐forward loop may underlie clinical depression. However, in the majority of studies, repeated or chronic stress has been shown to decrease the behavioral and the neurochemical responsivity to acute stressors. Repeated stress also seems to decrease the responsivity of LC neurons to CRF. These results do not provide support for a feed‐forward hypothesis. However, a few studies using certain tasks have indicated sensitization, and some other studies have suggested that the effect of CRF may be dose dependent. Further investigations are necessary to establish the validity or otherwise of the feed‐forward hypothesis.
- 1 June 2004
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1018 (1) , 25-34
Brain Circuits Involved in Corticotropin‐Releasing Factor‐Norepinephrine Interactions during Stress
Abstract: Corticotropin‐releasing factor (CRF)‐ and norepinephrine (NE)‐containing neurons in the brain are activated during stress, and both have been implicated in the behavioral responses. NE neurons in the brain stem can stimulate CRF neurons in the hypothalamic paraventricular nucleus (PVN) to activate the hypothalamic‐pituitary‐adrenocortical axis and may affect other CRF neurons. CRF‐containing neurons in the PVN, the amygdala, and other brain areas project to the area of the locus coeruleus (LC), and CRF injected into the LC alters the electrophysiologic activity of LC‐NE neurons. Neurochemical studies have indicated that CRF applied intracerebroventricularly or locally activates the LC‐NE system, and microdialysis and chronoamperometric measurements indicate increased NE release in LC‐NE terminal fields. However, chronoamperometric studies indicated a significant delay in the increase in NE release, suggesting that the CRF input to LC‐NE neurons is indirect. The reciprocal interactions between cerebral NE and CRF systems have been proposed to create a “feed‐forward” loop. It has been postulated that a sensitization of such a feed‐forward loop may underlie clinical depression. However, in the majority of studies, repeated or chronic stress has been shown to decrease the behavioral and the neurochemical responsivity to acute stressors. Repeated stress also seems to decrease the responsivity of LC neurons to CRF. These results do not provide support for a feed‐forward hypothesis. However, a few studies using certain tasks have indicated sensitization, and some other studies have suggested that the effect of CRF may be dose dependent. Further investigations are necessary to establish the validity or otherwise of the feed‐forward hypothesis.
- 1 May 2003
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 992 (1) , 21-29
HPA Axis Activation and Neurochemical Responses to Bacterial Translocation from the Gastrointestinal Tract
Abstract:Stress can cause migration of indigenous bacterial flora from the gut to the peritoneum, a phenomenon known as bacterial translocation. Destruction of the cell walls of gram‐negative bacteria can result in the production of endotoxin (lipopolysaccharide, LPS), which is the likely cause of sepsis. Exogenously administered LPS can activate the hypothalamo‐pituitary‐adrenal (HPA) axis as well as brain noradrenergic and indoleaminergic systems. Thus, it is possible that activations of these systems associated with laboratory stressors in rats and mice could be attributed to bacterial translocation and LPS production. To test this hypothesis we conducted experiments on the time course of bacterial translocation in response to restraint in mice, while measuring HPA and neurochemical responses. These experiments failed to show good correlations between the occurrence of bacterial translocation and HPA and neurochemical activations, suggesting that the later responses were not linked to bacterial translocation. This conclusion was supported by the observation of normal neurochemical responses to restraint in germ‐free mice. In further experiments, translocation ofSalmonella typhimurium, a bacterium that readily translocates in unstressed animals, was associated with HPA activation and noradrenergic and indoleaminergic responses, indicating that bacterial translocation can indeed activate the HPA axis and brain amines. However, the above experiments suggest that this is not the mechanism by which restraint activates these systems.
- 1 May 2003
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 992 (1) , 21-29
HPA Axis Activation and Neurochemical Responses to Bacterial Translocation from the Gastrointestinal Tract
Abstract:Stress can cause migration of indigenous bacterial flora from the gut to the peritoneum, a phenomenon known as bacterial translocation. Destruction of the cell walls of gram‐negative bacteria can result in the production of endotoxin (lipopolysaccharide, LPS), which is the likely cause of sepsis. Exogenously administered LPS can activate the hypothalamo‐pituitary‐adrenal (HPA) axis as well as brain noradrenergic and indoleaminergic systems. Thus, it is possible that activations of these systems associated with laboratory stressors in rats and mice could be attributed to bacterial translocation and LPS production. To test this hypothesis we conducted experiments on the time course of bacterial translocation in response to restraint in mice, while measuring HPA and neurochemical responses. These experiments failed to show good correlations between the occurrence of bacterial translocation and HPA and neurochemical activations, suggesting that the later responses were not linked to bacterial translocation. This conclusion was supported by the observation of normal neurochemical responses to restraint in germ‐free mice. In further experiments, translocation ofSalmonella typhimurium, a bacterium that readily translocates in unstressed animals, was associated with HPA activation and noradrenergic and indoleaminergic responses, indicating that bacterial translocation can indeed activate the HPA axis and brain amines. However, the above experiments suggest that this is not the mechanism by which restraint activates these systems.
- 1 December 2001
- Published by S. Karger AG in Neuroimmunomodulation
- Vol. 9 (3) , 163-169
The Reductions in Sweetened Milk Intake Induced by Interleukin-1 and Endotoxin Are Not Prevented by Chronic Antidepressant Treatment
Administration of interleukin-1 (IL-1) and endotoxin (lipopolysaccharide, LPS) to rodents can decrease food intake, a behavioral response resembling the diminution of appetite observed in human depression. IL-1 and LPS are known to affect cerebral neurotransmission involving norepinephrine and serotonin, both of which have been implicated in feeding behavior and in the pharmacotherapy of depression in man. The ability of chronic antidepressant treatment to attenuate LPS-induced depressed feeding in rats has been cited as evidence that cytokines may be involved in human depression. Thus, we studied the effects of chronic treatment with the tricyclic antidepressant, imipramine, and the novel antidepressant, venlafaxine, on the sweetened milk intake challenged with intraperitoneally injected IL-1β and LPS. Chronic (from 2 to 8 weeks) treatment of the mice with imipramine (10 mg/kg once or twice daily) or venlafaxine (10 and 20 mg/kg/day) did not significantly alter the decreases in milk intake in response to mIL-1β or LPS. In some experiments, chronic imipramine slightly decreased body weight and slightly increased milk intake, but not food pellet intake. Venlafaxine had none of these effects. Analysis of variance did not indicate any significant interactions between the antidepressant and IL-1 or LPS treatments. These results indicate that chronic treatment with antidepressants does not significantly alter the responses to IL-1 or LPS in the mouse sweetened milk model of sickness behavior.
- 1 December 2001
- Published by S. Karger AG in Neuroimmunomodulation
- Vol. 9 (3) , 163-169
The Reductions in Sweetened Milk Intake Induced by Interleukin-1 and Endotoxin Are Not Prevented by Chronic Antidepressant Treatment
Administration of interleukin-1 (IL-1) and endotoxin (lipopolysaccharide, LPS) to rodents can decrease food intake, a behavioral response resembling the diminution of appetite observed in human depression. IL-1 and LPS are known to affect cerebral neurotransmission involving norepinephrine and serotonin, both of which have been implicated in feeding behavior and in the pharmacotherapy of depression in man. The ability of chronic antidepressant treatment to attenuate LPS-induced depressed feeding in rats has been cited as evidence that cytokines may be involved in human depression. Thus, we studied the effects of chronic treatment with the tricyclic antidepressant, imipramine, and the novel antidepressant, venlafaxine, on the sweetened milk intake challenged with intraperitoneally injected IL-1β and LPS. Chronic (from 2 to 8 weeks) treatment of the mice with imipramine (10 mg/kg once or twice daily) or venlafaxine (10 and 20 mg/kg/day) did not significantly alter the decreases in milk intake in response to mIL-1β or LPS. In some experiments, chronic imipramine slightly decreased body weight and slightly increased milk intake, but not food pellet intake. Venlafaxine had none of these effects. Analysis of variance did not indicate any significant interactions between the antidepressant and IL-1 or LPS treatments. These results indicate that chronic treatment with antidepressants does not significantly alter the responses to IL-1 or LPS in the mouse sweetened milk model of sickness behavior.